welcome to oneEDSvoice
- a positively charged Ehlers Danlos Syndrome community.- join today!
- login
scientific articles
The Successful Use of Recombinant Factor VIIa in a Patient with Vascular-Type Ehlers-Danlos Syndrome
source: Acta Anaesthesiologica Scandinavica
year: 2007
authors: Faber P, Craig WL, Duncan JL, Holliday K
summary/abstract:Vascular-type Ehlers-Danlos syndrome is an inherited connective tissue disorder resulting in an increased risk of serious peri-operative bleeding during surgery for spontaneous organ or vessel rupture. The excessive bleeding may result in coagulopathy, and thus compound the difficulty in securing surgical haemostasis. With the advent of recombinant factor VIIa, a new therapy has become available for the management of intractable surgical bleeding.
organisation: Aberdeen Royal InfirmaryDOI: 10.1111/j.1399-6576.2007.01416.x
read more full text source
expertly curated content related to this topic
-
Periodontal Ehlers-Danlos Syndrome Is Caused by Mutations in C1R and C1S, which Encode Subcomponents C1r and C1s of ...Periodontal Ehlers-Danlos syndrome (pEDS...
-
Spontaneous Coronary Artery Dissection in Ehlers-Danlos SyndromeEhlers-Danlos syndrome is a heterogeneou...
-
Cincinnati Children’s – The Connective Tissue ClinicThe Connective Tissue Clinic at Cincinna...
-
BradLey Tinkle, MDBrad Tinkle, MD, PhD, is a clinical and ...
-
University Health Network (UHN)UHN Foundations work as catalysts to tra...
-
Ehlers-Danlos syndrome (Satumaan)Zebra is the mascot for Ehlers Danlos sy...
-
ANSEDH, Asociación Nacional del Síndrome de Ehlers-Danlos e HiperlaxitudANSEDH, National Association of Ehlers-D...